Roger Kang is the vice president of Princeton BioMeditech Corporation (PBM) and president of LifeSign, which are medical diagnostic companies delivering high-quality, rapid point-of-care testing solutions worldwide. PBM, a family-owned company, specializes in point-of-care tests related to fertility, infectious disease, drugs, tumors, cardiology, and veterinary and environmental diagnostics, including: the one-step pregnancy test, rapid COVID-19/influenza A & B panel test, and the rapid 3-in-1 cardiac marker panel. In 2012, Mr. Kang established an endowment for the Kang Family Graduate Fellowship for Biotechnology at UC Berkeley. In 2022, Kang was instrumental in helping to fund and launch the new Masters in Biotechnology program. He serves as chair of the UC Berkeley Foundation’s Nominations Committee and as a member of the Executive Committee. Mr. Kang is also an active member of the New York Chancellor’s Council and formerly served as co-chair of this group. In 2022, he was a recipient of the Campanile Excellence in Achievement Award. He is a Builder of Berkeley.
Job title:
President, LifeSign LLC; Vice President,Princeton BioMeditech Corporation
Bio/CV:
Role:
